Kcl Capital, L.P. Codex Dna, Inc. Transaction History

Kcl Capital, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$4.12 - $10.36 $41,958 - $105,506	-10,184 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$6.31 - $11.96 $51,136 - $96,923	-8,104 Reduced 44.31%	10,184 $110,000
Q3 2021 Nov 15, 2021	SELL	$10.15 - $19.88 $68,126 - $133,434	-6,712 Reduced 26.85%	18,288 $204,000
Q2 2021 Aug 16, 2021	BUY	$17.76 - $22.0 $444,000 - $550,000	25,000 New	25,000 $550,000

307

Ticker DNAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 29,518,200
Market Cap $54.6M
Description
Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA...

Get notified when there are updates to the investment portfolio of Kcl Capital, L.P., based on Form 13F filings with the SEC.

Stay updated on Kcl Capital, L.P. with notifications on news.